IL6 and hepatocellular carcinoma: Both HCV and HBV induce IL-6 production, while increased IL-6 levels are poor prognostic marker for either treatment outcome (HCV, Guzman-Fulgencio et al., 2012) or HCC severity (HBV, Chang et al., 2015).